Wicab
6
0
0
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 75/100
16.7%
1 terminated/withdrawn out of 6 trials
75.0%
-11.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (6)
Evaluation of the Efficacy of the BrainPort Vision Pro on the Performance of Daily Activities in the Profoundly Blind French Population
Role: lead
A Study to Evaluate the BrainPort Vision Device in Individuals Blinded by Traumatic Injury
Role: lead
A Study to Evaluate the BrainPort® Vision Device in Subjects Who Are Blind
Role: lead
Safety and Efficacy Study of BrainPort® Balance Device in Peripheral Vestibular Dysfunction.
Role: lead
Use of the BrainPort® Balance Device to Improve Balance in Adults With Balance Deficits Due to Stroke
Role: lead
Safety and Efficacy of the BrainPort™ Balance Device to Improve Balance in Bilateral Vestibular Hypofunction
Role: lead
All 6 trials loaded